Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Centene Corporation due to misleading statements regarding the company's enrollment and morbidity rates, which led to a significant decline in stock price [4][6]. Group 1: Legal Investigation - Faruqi & Faruqi is reminding investors of the September 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action against Centene [4]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [5]. Group 2: Company Performance and Stock Impact - Centene provided positive statements while concealing adverse facts about its enrollment and morbidity rates, leading to investor skepticism [6]. - On July 1, 2025, Centene withdrew its 2025 guidance, stating that its market growth across 22 states was lower than expected, resulting in a revised guidance of approximately $1.8 billion or an adjusted diluted EPS of $2.75 [6]. - Following this announcement, Centene's stock price plummeted from $56.65 per share to $33.78 per share, marking a decline of 40.4% [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of violations of federal securities laws, particularly concerning misleading statements and illegal kickbacks related to Medicare beneficiaries [4][6][7]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, regardless of the quality of the plans [6]. - It is claimed that SelectQuote did not provide unbiased comparisons for Medicare Advantage insurance plans and received illegal kickbacks from insurers [6]. - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021, leading to a significant drop in stock price [7]. Group 2: Legal Proceedings and Investor Actions - Investors who suffered losses exceeding $75,000 between September 9, 2020, and May 1, 2025, are encouraged to discuss their legal rights with Faruqi & Faruqi [1][4]. - There is a deadline of October 10, 2025, for investors to seek the role of lead plaintiff in the federal securities class action against SelectQuote [4]. - The lead plaintiff is defined as the investor with the largest financial interest who can adequately represent the class [8].